Chromosomal profiles of gene expression in Huntington's disease

被引:39
作者
Anderson, Alexander N. [2 ]
Roncaroli, Federico [1 ]
Hodges, Angela [3 ]
Deprez, Manuel [4 ]
Turkheimer, Federico E. [1 ,2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Civil Neurosci, Div Neurosci & Mental Hlth, Hammersmith Hosp, London W12 0NN, England
[2] Hammersmith Hosp, MRC Clin Sci Ctr, London, England
[3] Inst Psychiat, MRC Ctr Neurodegenerat Res, London, England
[4] Univ Hosp Liege, Dept Pathol, Neuropathol Lab, Liege, Belgium
基金
英国医学研究理事会;
关键词
Huntington's disease; microarrays; histone deacetylase; chromosomal expression; Chromowave;
D O I
10.1093/brain/awm312
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent studies suggested that Huntington's disease is due to aberrant interactions between mutant huntingtin protein, transcription factors and transcriptional co-activators resulting in widespread transcriptional dysregulation. Mutant huntingtin also interacts with histone acetyltransferases, consequently interfering with the acetylation and deacetylation states of histones. Because histone modifications and chromatin structure coordinate the expression of gene clusters, we have applied a novel mathematical approach, Chromowave, to analyse microarray datasets of brain tissue and whole blood to understand how genomic regions are altered by the effects of mutated huntingtin on chromatin structure. Results show that, in samples of caudate and whole blood from Huntington's disease patients, transcription is indeed deregulated in large genomic regions in coordinated fashion, that transcription in these regions is associated with disease progression and that altered chromosomal clusters in the two tissues are remarkably similar. These findings support the notion of a common genome-wide mechanism of disruption of RNA transcription in the brain and periphery of Huntington's disease patients.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 29 条
  • [1] Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease
    Borovecki, F
    Lovrecic, L
    Zhou, J
    Jeong, H
    Then, F
    Rosas, HD
    Hersch, SM
    Hogarth, P
    Bouzou, B
    Jensen, RV
    Krainc, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (31) : 11023 - 11028
  • [2] Brune N, 2004, J NEURAL TRANSM-SUPP, P105
  • [3] Histone deacetylase inhibitors as therapeutics for polyglutamine disorders
    Butler, Rachel
    Bates, Gillian P.
    [J]. NATURE REVIEWS NEUROSCIENCE, 2006, 7 (10) : 784 - 796
  • [4] Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes
    Chattopadhyay, B
    Baksi, K
    Mukhopadhyay, S
    Bhattacharyya, NP
    [J]. NEUROSCIENCE LETTERS, 2005, 374 (02) : 81 - 86
  • [5] Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease
    Chen-Plotkin, AS
    Sadri-Vakill, G
    Yohrling, GJ
    Bravernan, MW
    Berin, CL
    Glajch, KE
    DiRocco, DP
    Farrella, LA
    Krainc, D
    Gines, S
    MacDonald, ME
    Cha, JHJ
    [J]. NEUROBIOLOGY OF DISEASE, 2006, 22 (02) : 233 - 241
  • [6] Signaling to chromatin through histone modifications
    Cheung, P
    Allis, CD
    Sassone-Corsi, P
    [J]. CELL, 2000, 103 (02) : 263 - 271
  • [7] Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates
    Dalrymple, Annette
    Wild, Edward J.
    Joubert, Richard
    Sathasivam, Kirupa
    Bjorkqvist, Maria
    Petersen, Asa
    Jackson, Graham S.
    Isaacs, Jeremy D.
    Kristiansen, Mark
    Bates, Gillian P.
    Leavitt, Blair R.
    Keir, Geoff
    Ward, Malcolm
    Tabrizi, Sarah J.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2007, 6 (07) : 2833 - 2840
  • [8] Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements
    DiProspero, NA
    Chen, EY
    Charles, V
    Plomann, M
    Kordower, JH
    Tagle, DA
    [J]. JOURNAL OF NEUROCYTOLOGY, 2004, 33 (05): : 517 - 533
  • [9] Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16
    Djoussé, L
    Knowlton, B
    Hayden, MR
    Almqvist, EW
    Brinkman, RR
    Ross, CA
    Margolis, RL
    Rosenblatt, A
    Durr, A
    Dode, C
    Morrison, PJ
    Novelletto, A
    Frontali, M
    Trent, RJA
    McCusker, E
    Gómez-Tortosa, E
    Cabrero, DM
    Jones, R
    Zanko, A
    Nance, M
    Abramson, RK
    Suchowersky, O
    Paulsen, JS
    Harrison, MB
    Yang, Q
    Cupples, LA
    Mysore, J
    Gusella, JF
    MacDonald, ME
    Myers, RH
    [J]. NEUROGENETICS, 2004, 5 (02) : 109 - 114
  • [10] FARRER LA, 1993, AM J HUM GENET, V53, P125